Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Sangryong | - |
dc.contributor.author | Lee, Ho-Young | - |
dc.contributor.author | Kim, Jayoung | - |
dc.contributor.author | Park, Hansol | - |
dc.contributor.author | Ju, Young Seok | - |
dc.contributor.author | Kim, Eung-Gook | - |
dc.contributor.author | Kim, Jaehong | - |
dc.date.available | 2021-03-22T01:40:34Z | - |
dc.date.created | 2021-03-15 | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 2072-6694 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80503 | - |
dc.description.abstract | Enhanced Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TAZ) signaling is correlated with the extraprostatic extension of prostate cancer. However, the mechanism by which YAP/TAZ signaling becomes hyperactive and drives prostate cancer progression is currently unclear. In this study, we revealed that higher expression of CCM1, which is uniquely found in advanced prostate cancer, is inversely correlated with metastasis-free and overall survival in patients with prostate cancer. We also demonstrated that CCM1 induces the metastasis of multiple types of prostate cancer cells by regulating YAP/TAZ signaling. Mechanistically, CCM1, a gene mutated in cerebral cavernous malformation, suppresses DDX5, which regulates the suppression of YAP/TAZ signaling, indicating that CCM1 and DDX5 are novel upstream regulators of YAP/TAZ signaling. Our findings highlight the importance of CCM1-DDX5-YAP/TAZ signaling in the metastasis of prostate cancer cells. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | Cancers | - |
dc.title | Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000627936600001 | - |
dc.identifier.doi | 10.3390/cancers13051125 | - |
dc.identifier.bibliographicCitation | Cancers, v.13, no.5 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85101955205 | - |
dc.citation.title | Cancers | - |
dc.citation.volume | 13 | - |
dc.citation.number | 5 | - |
dc.contributor.affiliatedAuthor | Park, Sangryong | - |
dc.contributor.affiliatedAuthor | Lee, Ho-Young | - |
dc.contributor.affiliatedAuthor | Kim, Jaehong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Cerebral cavernous malformation | - |
dc.subject.keywordAuthor | DDX5 | - |
dc.subject.keywordAuthor | Metastasis | - |
dc.subject.keywordAuthor | Prostate cancer | - |
dc.subject.keywordAuthor | YAP/TAZ signaling | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.